CD388

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameCD388
Drug Alias NameCD-388JNJ-0953CD388
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCidara Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals IncMerck Sharp & Dohme CorpCidara Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A